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Abstract
Neural stem cells (NSCs) are undifferentiated cells in the central nervous system (CNS) that are capable of self-renewal and
can be induced to differentiate into neurons and glia. Current sources of mammalian NSCs are confined to regions of the
CNS that are critical to normal function and surgically difficult to access, which limits their therapeutic potential in human
disease. We have found that the filum terminale (FT), a previously unexplored, expendable, and easily accessible tissue at the
caudal end of the spinal cord, is a source of multipotent cells in postnatal rats and humans. In this study, we used a rat
model to isolate and characterize the potential of these cells. Neurospheres derived from the rat FT are amenable to in vitro
expansion in the presence of a combination of growth factors. These proliferating, FT-derived cells formed neurospheres
that could be induced to differentiate into neural progenitor cells, neurons, astrocytes, and oligodendrocytes by exposure
to serum and/or adhesive substrates. Through directed differentiation using sonic hedgehog and retinoic acid in
combination with various neurotrophic factors, FT-derived neurospheres generated motor neurons that were capable of
forming neuromuscular junctions in vitro. In addition, FT-derived progenitors that were injected into chick embryos survived
and could differentiate into both neurons and glia in vivo.
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Introduction
Both neural stem cells (NSCs), which are capable of unlimited
self-renewal, and neural progenitor cells (NPCs), which have a
more restricted potential, hold great promise for cell replacement
strategies to treat neurological diseases [1]. The hope is for these
cells to replace those lost due to a disease process or trauma [2,3].
In order for this strategy to be successful, NPCs have to produce
the appropriate cell types in appropriate numbers and must
integrate into the host nervous system to reproduce the correct
circuitry. In addition, the transplanted cells cannot lead to tumor
formation or initiate an immunological reaction.
The presence of multipotent NSCs has previously been
demonstrated in multiple regions of the adult mammalian CNS
in species ranging from rats to humans. These regions include the
olfactory bulb [4], subependymal lining of the ventricles [5–9],
hippocampus [10,11], cerebellum [12,13], spinal cord [14,15],
and retina [16,17]. Recent studies have used isolated NSCs to
generate specific neuronal types in vitro, such as retinal [18–21],
dopaminergic [22–25], and cholinergic neurons [26–28]. In
addition, NSCs transplanted into mammalian brains have retained
their ability to generate various cell lineages and have survived in
vivo [29–32].
Despite rapid advances in NSC biology, current sources of
mammalian NPCs are not ideal for transplantation therapy in
human disease because they are obtained from regions that are
difficult to access and are critical to normal brain function.
Surgical disruption of these areas leads to profound neurological
deficits, which renders their use impractical for harvesting
autologous NPCs.
The FT is an excellent candidate as a source of autologous,
multipotent cells. It provides distinct advantages over the presently
available sources in that it is both easily accessible and an
expendable tissue that persists in adults. It also has the potential to
be used for autologous replacement therapy, thereby avoiding
immunological problems. We have considered exploring the FT as
a potential source of multipotent cells because of its unique
developmental history [33], histologic environment [34], and
propensity to produce neuroectodermal tumors [35]. Early in
development, the FT provides innervation to the embryo’s
presumptive tail (or in rodents, temporary innervation of caudal-
most tail segments). As development continues, the coccygeal/tail
portion of the spinal cord gets reabsorbed and the cells undergo a
process termed by Streeter as ‘‘de-differentiation’’ [33,36]
(Figure 1). The coccygeal spinal cord reverts to an earlier
embryonic tissue type, which results in a collagenous structure
with a narrow central canal that is lined by ependymal cells and
surrounded by a loosely organized collection of fibroblasts,
neurons, and glia [33,36–38]. The resulting structure persists in
adults as the FT, a slender prolongation of the caudal end of the
spinal cord that anchors it to the coccyx. The postnatal FT is not
interconnected with the rest of the nervous system, nor does it
innervate the body. It is a vestigial remnant that is routinely
sectioned in humans with a condition known as tethered cord
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Figure 1. Developmental history of the FT. a) Illustration of two stages of a human embryo by Streeter (1919) [33], which demonstrates the de-
differentiation of the caudal spinal cord into the filum terminale (FT) following the re-absorption of the vestigial tail. The numbers below the drawing
indicate the length of the embryo. b) Drawings by Kunitomo (1918) [36]of the process of re-absorption of the embryonic tail. The numbers below the
illustrations indicate the age in weeks of the fetus, and the numbers above represent the length in millimeters.
doi:10.1371/journal.pone.0065974.g001
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syndrome. In these cases, the spinal cord is tightly tethered to the
spine and lacks sufficient freedom of movement, so the FT is
sectioned to relieve that tension [39,40].
The histology of the FT has similarities to other CNS regions
that have been previously described as NSC niches [41]. It
contains peri-ventricular ependymal cells and a loosely organized
collection of fibroblasts, neurons, and glia surrounding the canal
[34,38,42–44]. In rats, FT neurons have been described as smaller
than usual and are hypothesized to possibly represent neurons in
an early stage of commitment and differentiation [45]. Paragan-
gliomas and other primitive neuroectodermal tumors arise from
the adult FT, again suggesting the possibility that NSCs are
present [35,46–48].
Recently, three laboratories (including our own) have identified
NPCs in the human FT. In a preliminary study, Varghese et al.
(2009) isolated neurospheres from the FT of four patients with
intraspinal tumors and demonstrated that they could generate
neurons and glia [49]. Arvidsson et al. (2011) identified NSC/NPC
markers in tissue isolated from both human and rat FT. They
isolated, expanded, and differentiated neurospheres from 13 out of
21 patients ranging in age from 1 to 60 years and noted a donor
age-dependent decrease in proliferative potential. In addition, they
isolated neurospheres from 5 out of 13 rat FTs [50]. Our
laboratory has reported isolating neurospheres from the FTs of 4
fetal and 33 postnatal donors (6 months to 18 years) that were able
to generate both neurons and glia. These neurospheres could also
be induced to differentiate into motor neurons capable of
innervating rat muscle in vitro. In agreement with the findings of
Arvidsson et al., FT tissue sections derived from 3 postnatal
surgeries and from 6 autopsies (51–81 years old) stained positively
for NSC/NPC markers [51].
A major difficulty in studying NPCs from the human FT is the
variability of the sources. The tissue is typically obtained from
tethered cord surgeries, and the donor age can vary from a few
months postnatal to adulthood. The precise location of the tissue
and the manner in which it is handled (including time to culture)
also varies from operation to operation and naturally between
clinical centers [39,40]. Therefore, we sought to develop a rodent
model for studying the FT that would permit the standardization
of experiments, provide unlimited amounts of tissue, allow
sampling at particular stages of the life cycle, and permit the use
of transgenic animals. In this paper, we report the establishment
and characterization of a rat model for generating NPCs from the
FT.
Materials and Methods
Ethics statement
All experiments have been approved by the Institutional Animal
Care and Use Committee at Harvard Medical School (protocol
#04305) and were conducted in accordance with the NIH Guide
for the Care and Use of Laboratory Animals.
Culturing FT-derived neurospheres
Primary Culture. All experiments were conducted accord-
ing to the guidelines of Harvard Medical School’s Institutional
Animal Care and Use Committee. Postnatal Sprague-Dawley rats
(Charles River, Wilmington, MA) aged P1–P12 were anesthetized
with isoflurane (Abbott, Abbott Park, IL) and killed by cervical
dislocation. The vertebral column was rapidly dissected in ice-cold
Hank’s buffered saline solution (HBSS). The FT was visualized
and identified under a microscope then dissected as illustrated in
Figure 2a. Each dissection was completed in less than 5 minutes to
minimize cell death. For most experiments, ,3 FTs were pooled
and transferred into a culture dish containing DMEM/F12 (1:1),
10% fetal bovine serum (FBS), and 100 U/ml collagenase type II
with 3 mM calcium. For experiments designed to determine the
yield of neurospheres as a function of age, one FT was used per
culture. The cultures were mechanically dissected and maintained
in a humidified incubator at 37uC with 5% CO2. Within 15–
24 hours, the tissue was rinsed, triturated, and transferred into
stem cell medium (SCM; [14,52–55] containing DMEM/F12
(1:1), 1% N2 and 2% B27 supplements, EGF (20 ng/ml), and
bFGF (20 ng/ml) (Invitrogen, Carlsbad, CA). The bFGF was
prepared in a solution containing 8 mg/ml heparin (Sigma, St.
Louis, MO) for stability. Primary stem cell proliferation was
detected after 3–5 days in vitro and was characterized by the
formation of spheres of undifferentiated cells [9].
Passaging Cultures. The cultures were passaged every 2–3
weeks. Neurospheres were incubated with 1X AccumaxTM
(Innovative Cell Technologies, San Diego, CA) for 5–8 min at
37uC followed by mechanical trituration to achieve partial
dissociation. Similar results were achieved through mechanical
trituration alone. Additionally, a single cell suspension could be
achieved by filtering the mechanically dissociated cells through a
100 mm cell strainer (BD Falcon, Franklin Lakes, NJ). The cells
were then centrifuged for 10 min at 1000 rpm and resuspended in
a 1:1 combination of fresh and conditioned medium.
Immunocytochemistry
Whole or differentiated neurospheres were attached to glass
coverslips, fixed with 4% formaldehyde in PBS (pH 7.4) for 20–
30 minutes, and washed thoroughly in PBS. Primary antibodies
were diluted in blocking solution (10% normal goat serum, 10%
fish skin gelatin, 0.3% Triton X-100, and 0.2% bovine serum
albumin in PBS), and each coverslip was incubated with the
appropriate primary antibody overnight at 4uC [goat polyclonal
anti-Nestin (1:50; R&D Systems), mouse monoclonal anti-Nestin
(1:100; Millipore, Billerica, MA), mouse monoclonal Olig-2
(prediluted, Dr. Connie Cepko, HMS), mouse monoclonal anti-
Vimentin (Zymed), rabbit polyclonal anti-Sox2 (1:1000; Abcam,
Cambridge, MA), rabbit polyclonal anti-b-tubulin III (Tuj-1;
1:1000; Covance, Princeton, NJ), rabbit polyclonal anti-GFAP
(1:1000; DAKO, Glostrup, Denmark), mouse monoclonal anti-
GFAP (1:1000, Sigma), mouse monoclonal Pax6 (developed by
Kawakami, A), mouse monoclonal anti-MNR2 (Developmental
Studies Hybridoma Bank, NICHD, University of Iowa Depart-
ment of Biological Sciences, Iowa City, IA)], goat polyclonal anti-
ChAT (1:100; Millipore), mouse monoclonal anti-MBP (1:500,
Covance), mouse monoclonal anti-neuron specific enolase (1:1000;
Millipore), and rabbit polyclonal anti-Hsp27 (1:1000; Enzo Life
Sciences, Farmingdale, NY)]. The coverslips were then washed in
PBS and incubated with the appropriate secondary antibody for
4 hours [AlexaFluor488-conjugated donkey anti-rabbit, Alexa-
Fluor488-conjugated donkey anti-mouse, AlexaFluor568-conju-
gated donkey anti-goat, AlexaFluor488-conjugated goat anti-
mouse, and AlexaFluor568-conjugated goat anti-rabbit (all
1:1000; Invitrogen)]. Finally, the coverslips were washed, incubat-
ed with DAPI (0.03 mg/ml) for 30 minutes, washed again, and
then mounted on glass slides with Vectashield mounting media
(Vector Labs). The slides were visualized for immunofluorescence
using a Zeiss photomicroscope and/or with confocal microscopy.
The approximate proportions of cells staining for a particular
marker were determined by the average count of 4–5 20X fields
that were randomly chosen by an unbiased observer. Cell counts
were based on DAPI-stained nuclei.
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Rat muscle culture
Rats aged P0–P7 were sacrificed as described above, and their
proximal limb muscles were rapidly dissected in ice-cold HBSS,
gently teased apart, and transferred to culture dishes containing
DMEM/F12 (1:1), 1% N2 supplement, and 1% penicillin-
streptomycin. Collagenase type II (100 U/ml) with 3 mM calcium
was included to dissociate the muscle fibers into single cells. The
dishes were incubated at 37uC with 5% CO2 for 24 hours, after
which the cultures were triturated with a fire-polished Pasteur
pipette to completely dissociate the tissue and centrifuged for
5 minutes at 1000 rpm. The pellets were washed with PBS and
resuspended in medium containing DMEM/F12 (1:1), 1% N2
supplement, 1% penicillin-streptomycin, and 10% FBS. Cis-
hydroxyproline (100 mg/ml; Sigma) was added to suppress
fibroblast proliferation. The cells were plated at a density of
,106 cells/ml on coverslips coated with poly-L-lysine (0.01%;
Sigma) and laminin (20 mg/ml; Sigma).
In vitro differentiation
Non-specific differentiation. Single neurospheres were
visualized under a dissecting microscope, isolated, and plated on
glass coverslips coated with poly-L-lysine (0.01%) and laminin
(20 mg/ml) in individual wells of a 96-well culture dish that
contained DMEM/F12 (1:1) with 1% N2, 1% penicillin-strepto-
mycin, and 5–10% FBS. This media was not changed for the
remainder of the experiment. The coverslips were processed for
immunocytochemistry either 24 hours or 7–10 days later.
Incubation with tritiated thymidine. Thymidine labeling
experiments were conducted as previously described [56]. Briefly,
neurospheres were incubated with 3H thymidine (NEN, 5 mCi/ml;
89 Ci/mmol) in SCM for 8 hours. The individual neurospheres
were isolated, washed 3X in SCM, and differentiated in serum as
described above. After differentiation, the coverslips were
processed for immunocytochemistry. Prior to mounting the
coverslips onto slides, emulsifier oil was added. After 2 days in
the dark, the emulsifier oil was removed, and the coverslips were
washed with water and then incubated in a developer for
4 minutes. Next, the developer was aspirated and the coverslips
were fixed in 4% paraformaldehyde for 20 minutes. Finally, the
coverslips were washed with water, mounted on slides with
Vectashield mounting media (Vector Laboratories, Burlingame,
CA), and visualized with fluorescence (for immunocytochemistry)
or brightfield microscopy (for tritiated thymidine incorporation).
Directed Differentiation. Neurospheres were treated with
retinoic acid (RA, 2 mM; Sigma) and either sonic hedgehog
protein (Shh-N, 400–1000 nM; R&D Systems, Minneapolis, MN)
or a small molecule agonist of sonic hedgehog signaling (Hh-
Ag1.3, Curis, Lexington, MA) in SCM for 4–5 days using a
Figure 2. Identification of neural progenitor cell (NPC) markers in the rat FT. a) Dissection of a P9 FT fixed in 4% formaldehyde. The arrow
indicates the start of the FT. b) Immunohistochemical staining of a whole mount P3 FT for the NPC marker Nestin (red, i) with the distribution of cells
indicated with DAPI (blue, ii). A merged image of b(i) and (ii) is shown in b(iii). Scale bar: 1 mm. c) Expression of Nestin (green) and DAPI (blue) in a
longitudinal section of a P1 FT. Scale bar: 50 mm. d) Expression of Nestin (red) and DAPI (blue) in a transverse section of a P1 FT. Scale bar: 20 mm. The
arrow in b(ii) indicates the location along the FT from which this section was taken.
doi:10.1371/journal.pone.0065974.g002
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modification of the previously described methods in Soundarar-
ajan et al. (2006) and Wichterle et al. (2002). Individual neuro-
spheres were then isolated and plated for 7–10 days on glass
coverslips coated with poly-L-ornithine (0.01%; Sigma), collagen
type I (0.01%), and laminin (20 mg/ml) in individual wells of 96-
well culture dishes (Corning) containing DMEM/F12 medium
(1:1) with 1% N2, 1% penicillin-streptomycin, 5% horse serum
(Invitrogen), CNTF (25 ng/ml; Sigma), GDNF (25 ng/ml;
Sigma), and BDNF (50 ng/ml; Sigma). Four conditions were
used: (1) neurospheres treated as above; (2) as above but without
RA; (3) as above without Shh or RA; (4) serum alone (without Shh,
RA, or the 3 neurotrophins). The coverslips were subsequently
processed for immunocytochemistry.
Neuromuscular junction formation. Individual neuro-
spheres were treated with RA (2 mM) and Shh-N (400–
1000 nM) for 4–6 days and subsequently plated on muscle
cultures in the differentiation media for motor neuron growth and
survival described above. We used two types of control cultures: 1)
myocytes alone and 2) myocytes onto which untreated neuro-
spheres were plated. After 6–21 days, the cultures were incubated
with AlexaFluor594-conjugated-a-bungarotoxin (2 mg/ml; Invi-
trogen) for 2.5 hours, washed, fixed, and processed for immuno-
cytochemistry. Single neurospheres were labeled for 1 hour prior
to co-culture with either 1 mM Di-I, Di-D, or carboxyfluorescein
diacetate succinimidyl ester (CFSE).
In vivo transplantation of FT-derived NPCs
Isolation of eGFP+ neurospheres. Transgenic rats express-
ing enhanced GFP under the chicken b-actin promoter and
cytomegalovirus enhancer (‘‘green rat’’ CZ-004, SD-Tg(Act-
EGFP)CZ-004Osb; SLC, Shizuoka, Japan) were obtained from
Dr. Kocsis at Yale University. Primary cultures of neurospheres
were established using the same protocol described above for
wildtype rats.
Transplantation of FT-derived NPCs into chick
embryos. GFP-expressing neurospheres were grown as de-
scribed above. After 4 ml of albumin had been removed to
accommodate the transplanted tissue, either whole neurospheres
or dissociated NPCs were implanted into a stage 10–17 chick
embryo at the rostral end of the developing spinal cord using a
pulled class pipette and microinjector apparatus. A saline control
was used to mimic NPC injection, and in some cases, 0.1% Fast
Green was co-injected to add contrast. The embryos were then
placed horizontally in a 38uC incubator until the tissue was
harvested at 3–7 days post-transplantation, fixed with 4% PFA,
sectioned at 20–50 mm, and labeled with appropriate antibodies to
assess the differentiation potential of the implanted NPCs.
Results
Characterization of the FT in vivo
The FT was isolated from rats aged P1–P12 (n= 63) by excising
the tissue at the caudal end of the spinal cord that extends past the
conus medullaris (Figure 2a). To verify the presence of NPCs in
the FT, a whole mount FT underwent immunohistochemical
staining for the NPC marker Nestin (tiled confocal images are
shown in Figure 2b(i)). Co-staining with the nuclear marker DAPI
indicates the overall distribution of cells throughout the FT
(Figure 2b(ii)). This result suggests that Nestin-positive cells are
present through the entire length of the FT (n= 14). To examine
the distribution of these Nestin-positive cells more closely, sections
were cut from the first third of the FT closest to the conus
medullaris (indicated by the arrow in Figure 2b(ii)). The pattern of
Nestin staining in longitudinal sections (n = 5) suggests that the
Nestin-positive cells possess long processes that extend from the
central canal to the pial surface, while their cell bodies reside
within or close to the ependymal zone (Figure 2c). The distribution
of Nestin-positive cells in transverse sections at the same location
along the length of the FT (n = 9) confirmed their morphology and
distribution (Figure 2d). These results suggest that NPCs are
indeed present in the FT.
Isolation and characterization of self-renewing FT-
derived neurospheres
Isolation. Cells isolated from the FT were dissociated with
collagenase and cultured in standard stem cell medium (DMEM/
F12+1% N2 supplement) containing bFGF (20 ng/ml) and EGF
(20 ng/ml) along with B27 (2%) and N2 (1%) supplements.
Previous studies have identified these mitogenic factors as
successful stimulants of NPC proliferation [14,53,57]. Each culture
was derived from a single donor rat (ages P4–P10). After 3–4 days
in vitro, neurospheres were observed in 96 out of the 100 primary
cultures. These neurospheres were primarily free-floating and
were identified by their spherical structure, phase bright appear-
ance, and regular cell membranes (Figure 3a). The neurospheres
initially appeared as smaller clusters of 3–4 round cells and
eventually grew into larger neurospheres. The size of these larger
neurospheres ranged widely from ,50 mm to .1 mm. Cell
clusters of ,30 mm were not counted as neurospheres [58]. The
number of neurospheres per primary culture varied from 1 to
more than 40. For a subset of the cultures, we examined the effect
of donor age upon the ability to produce neurospheres and the
number of neurospheres obtained and found no correlation with
age (Table 1). To demonstrate their capacity for proliferation and
self-renewal, neurospheres were dissociated and passaged up to 19
times. These cultures have been maintained in vitro for up to 7
months. Twelve cultures have been frozen, and two have been
tested for viability and were successfully recovered upon thawing.
Characterization. Contrary to earlier thinking, neuro-
spheres are not homogenous populations of cells, but have instead
been shown to be a heterogeneous collection of NSCs and NPCs
that likely have varying differentiation potentials [53,59,60]. We
characterized the FT-derived neurospheres using immunocyto-
chemistry to determine the expression of various NSC, NPC,
neuronal, and glial markers. Specifically, neurospheres were
stained for the NSC/NPC markers Nestin (n = 9), Sox2 (n= 8),
Vimentin (n = 6), Olig-2 (n = 3), and Musashi (n = 4), the neuron-
specific marker b-tubulin III (Tuj-1, n = 12), and the astrocyte
marker glial fibrillary acidic protein (GFAP, n= 12).
In all cases, a varying proportion of cells were positive for Nestin
(Figure 3b). In 4/9 cases, 100% of the cells in the neurosphere
were Nestin+, and this did not appear to be correlated with the
amount of time in culture. Staining for other neural progenitor
markers was variable. In 3/3 experiments, 100% of cells within the
neurosphere stained positive for Olig-2 with some areas showing
more intense staining (Figure 3c). Although all neurospheres had
some proportion of cells that stained positive for Vimentin and
Sox2, (Figures 3d,e, respectively), this percentage varied from 33–
100% for Vimentin and 40–100% for Sox-2. Musashi staining was
weak, with occasional clusters of high intensity staining (Figure 3f).
Tuj-1+ and GFAP+ cells were present in all neurospheres
(Figure 3g; n= 12). Every neurosphere contained some cells that
were positive for both markers, and this fraction varied greatly
among individual neurospheres. As shown in Figure 3g, there was
spatial clustering of cells expressing the different markers. While
this clustering was apparent in most neurospheres, the patterns
were variable.
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Differentiation of FT-derived neurospheres into neurons
and glia
Some neurospheres adhered to the cultureware and spontane-
ously differentiated into cells having the morphological character-
istics of neurons and glia without the addition or removal of factors
from the medium. We sought to determine the conditions required
to differentiate FT-derived neurospheres into neurons and glia.
After withdrawing bFGF and EGF, single neurospheres were
plated onto coverslips that had been treated with 7 different
combinations of adhesive substrates 6 exposure to 5–10% fetal
bovine serum (Table 2). For each condition, 5 experiments were
performed. After 7 days, the cultures were stained for Tuj-1,
neurofilament, O1, GFAP, and Nestin. Although the use of either
an adhesive substrate alone or serum alone was sufficient to initiate
morphological differentiation, the addition of serum resulted in a
more rapid differentiation. For example, an individual neuro-
sphere plated on a poly-L-lysine- and laminin-coated coverslip
began to exhibit morphological properties of differentiation after
42 hours (data not shown). In contrast, a neurosphere plated on a
laminin-coated coverslip and cultured in 10% serum-containing
medium began to differentiate after only 18 hours (Figures 4a,b).
In all cases, we detected cells derived from the neurospheres that
expressed either neuronal or glial markers including Tuj-1,
neurofilament, O1, and GFAP (data not shown).
All subsequent differentiation experiments (n = 65) were con-
ducted by withdrawing the growth factors, supplementing the
media with 5–10% fetal bovine serum, and plating single
neurospheres onto coverslips coated with both poly-L-lysine and
laminin. The cells were cultured under these conditions for
24 hours (n = 30) or 7–10 days (n = 35), and the cultures were
subsequently fixed for immunocytochemistry. Given the wide
distribution of neurosphere sizes used in these experiments, the
number of differentiated cells obtained ranged from ,50 to
.5000 cells per neurosphere, which correlated with the size of the
neurosphere that had been plated. Larger neurospheres (usually
.100 mm) were capable of generating .5000 differentiated cells.
In all cases, the cells began to migrate away from the original
neurosphere and develop extensive processes within 18 hours of
exposure to the differentiation conditions (Figure 4).
We next examined whether the neurospheres were capable of
producing NPCs, neurons, oligodendrocytes, and astrocytes by
assessing their expression of the NPC marker Vimentin (Figure 5a),
the neuronal marker Tuj-1 (Figure 5b), the oligodendrocyte
marker O1 (Figure 5d), and the astrocyte marker GFAP
(Figure 5e). In most cases, we double stained the cells derived
from a single neurosphere for two of these markers (Figures 5a,b).
FT-derived neurospheres had varied differentiation potentials;
however, we consistently observed neurons, oligodendrocytes, and
astrocytes in each experiment (n = 12). In addition to their
immunocytochemical profiles, Figure 5 also illustrates that the
differentiated cells displayed morphologies characteristic of neu-
rons, oligodendrocytes, and astrocytes.
To confirm that the differentiated cells were derived from
proliferative cells, we labeled actively dividing cells with tritiated
thymidine [51]. Neurospheres were treated with 3H for 8 hours
(n = 5). They were then washed and differentiated over 7 days in
the standard conditions described above. Derived cells were
stained for Tuj-1 and GFAP. In all 5 cases, 27–90% of the cells
identified immunologically as neurons and glia had incorporated
tritiated thymidine into their nuclei (data not shown). This
Figure 3. Characterization of FT-derived, undifferentiated
neurospheres by the expression of NPC, neuronal, and glial
markers. a) Phase microscopy of a single neurosphere derived from a
P10 FT culture after 10 days in vitro (DIV) and 1 passage. b) An
individual neurosphere derived from a P5 FT culture (5 DIV) stained for
the NPC marker Nestin (i, red), DAPI (ii, blue), and merged (iii). The
images in (c–f) are co-stained with DAPI (blue). c) The NPC marker Olig2
(red) is expressed in a neurosphere derived from a P7 FT culture (34
DIV). d) Expression of Vimentin (green) in a proportion of cells of an
individual neurosphere derived from a P7 FT culture (60 DIV). e)
Immunostaining of Sox2 (red) in some cells from a single neurosphere
isolated from a P6 FT culture (30 DIV). f) Weak staining of Musashi (red),
with some hot-spots, in a neurosphere isolated from a P6 FT culture (30
DIV). g) (i) Sparse expression of b-Tubulin III (Tuj-1) in a proportion of
cells of a neurosphere derived from a P7 FT culture (34 DIV). The
expression of GFAP in the same neurosphere (g-ii) is restricted to the
peripheral cells in vitro. (iii) Merged images of g(i) and (ii). Scale bars:
100 mm.
doi:10.1371/journal.pone.0065974.g003
Table 1. Lack of correlation between donor age and culture success/number of FT-derived neurospheres.
Donor Age (days) Fraction of cultures producing neurospheres Average number and range of neurospheres
P4 23/23 7.6; (2–18)
P5 21/22 10.8; (0–42)
P6 18/18 8.7; (1–31)
P9 3/3 6.7; (6–8)
A potential effect of donor age upon the ability to produce neurospheres and the number of neurospheres obtained was systematically examined on a subset of
cultures. Donor rats of all ages had a similar culture success rate, and similar numbers of neurospheres were obtained for all ages.
doi:10.1371/journal.pone.0065974.t001
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demonstrates that the derived cells were the progeny of actively
dividing cells.
Figure 6 illustrates the variable expression of Tuj-1 and GFAP
in 14 experiments comparing differentiation after 24 hours to
differentiation after 7–10 days. Neurospheres differentiated over
24 hours (n = 9) resulted in a high proportion of cells that double
stained for both neuronal and glial markers (Figure 6). In the case
of Tuj-1 and GFAP staining, 69614% (n= 5) of the cells were
double stained for the two markers. After 7–10 days, the
proportion of cells that double stained for both neuronal and glial
markers decreased significantly (Figure 6). In the case of Tuj-1 and
GFAP staining, only 13610% (n= 9) of the cells were double
stained for the two markers (Figures 5b, 6). On rare occasions,
after 7 days of differentiation, .85% of cells derived from a single
neurosphere expressed either a neuronal or glial marker (n = 2).
However, in most cases, no obvious predominance was observed,
and varying proportions of both neuronal and glial cells were
noted from the differentiation of a single neurosphere (Figures 5,6).
These varying proportions of Tuj-1+ and GFAP+ may reflect the
heterogeneous differentiation potential of each neurosphere. This
variation persisted in neurospheres either from the same source or
different sources regardless of the age of the rat.
FT-derived neurospheres can be directed to generate
motor neurons (MNs)
We next determined whether FT-derived neurospheres were
capable of generating spinal cord MNs that could be used in cell
replacement strategies in cases of spinal cord trauma or MN
degeneration. To produce MN progenitors, single neurospheres
were treated for 4–5 days with 2 mM retinoic acid and either 0.5–
1 mM sonic hedgehog protein (Shh-N) or 1.5 mM of the hedgehog
agonist Hh-Ag1.3. The neurospheres were subsequently plated on
an adhesive substrate in the presence of 5% horse serum and 3
Figure 4. Inducing differentiation of FT-derived neurospheres. a) An individual neurosphere from a P5 FT (42 DIV) was plated at T = 0 on a
laminin-coated coverslip and cultured in media that contained 10% serum. b) Morphological properties of differentiation were evident after 18 hours
of exposure to these differentiating conditions. Scale bar: 100 mm.
doi:10.1371/journal.pone.0065974.g004
Table 2. Conditions for FT-derived neurosphere
differentiation.
Immunocytochemical marker
Differentiating
Conditions O1 GFAP BTIII NeurofilamentNestin
Polylysine + + + + 2
Laminin + + + N.D 2
Serum + + + + 2
Polylysine+laminin + + + + 2
Polylysine+serum + + + + 2
Laminin+serum + + + + 2
Polylysine+laminin+serum + + + + 2
Seven different conditions involving various combinations of an adhesive
substrate with serum-containing medium were used to differentiate FT-derived
neurospheres. After 7 days, the differentiated cells were subsequently
immunostained for markers to identify neurons (bTIII, neurofilament), astrocytes
(GFAP), and oligodendrocytes (O1). Although all seven conditions generated
these cell types, exposing neurospheres to serum resulted in a more rapid
differentiation process. N.D.: not done.
doi:10.1371/journal.pone.0065974.t002
Figure 5. Differentiation of FT-derived neurospheres into
neurons, astrocytes, and oligodendrocytes. a) Differentiated cells
derived from a single neurosphere double stained for the NPC marker
Vimentin (red, a(i)), the astrocyte marker GFAP (green, a(ii)), and merged
and co-stained with DAPI (a(iii)). These cells were derived from a single
neurosphere that was plated on a poly-L-lysine- and laminin-coated
coverslip and grown in 10% serum-containing medium without EGF,
bFGF, and LIF for 7 days prior to immunocytochemistry. Donor: P4 FT
(15 DIV) after 1 passage. b) Differentiated neurons and glia from an
individual neurosphere double stained for the astrocyte marker GFAP
(green, b-i) and the neuronal marker Tuj-1 (red, b-ii). The merged image
co-stained with DAPI is shown in b-iii. Same conditions as (a). Donor:
P7 FT, 30 DIV. c) Phase image of differentiated cells from a FT-derived
neurosphere. d) Cells differentiated from a single neurosphere, stained
for the oligodendrocyte marker O1 (green) and DAPI (blue). Same
conditions as (a). Donor: P6 FT, 36 DIV. e) Cells derived from a single
neurosphere and cultured in the same differentiating conditions as (a)
were stained for the astrocyte marker GFAP (red) and DAPI (blue).
Donor: P7 FT, 30 DIV. Scale bars: a&c, 100 mm; b&d, 50 mm.
doi:10.1371/journal.pone.0065974.g005
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neurotrophic factors known to promote MN growth and survival
(ciliary-derived neurotrophic factor (CNTF), brain-derived neuro-
trophic factor (BDNF), and glia-derived neurotrophic factor
(GDNF); Soundararajan et al., 2006 and Wichterle et al., 2002).
In all experiments (n = 25), various proportions of the differenti-
ated cells expressed either MN progenitor or mature MN markers
(Figure 7). At first, various proportions of differentiated cells
expressed motor neuron progenitor markers including Olig2 and
Pax6 (Figure 7a). After 7–10 days, the fraction of MNs produced
by each neurosphere was determined using immunocytochemistry
for the MN marker Motor Neuron Restricted-2 (MNR-2;
Figure 7b). Motor neurons were further characterized by their
expression of the neuronal marker Tuj-1 as well as choline acetyl
transferase (ChAT), which is the enzyme necessary for the
synthesis of acetylcholine, the neurotransmitter used by motor
neurons (Figure 7c).
While neurospheres treated with Shh-N gave rise to differen-
tiated neurons, only 20–40% of these neurons expressed MN
markers such as MNR2, Isl1, Lim3 and ChAT (n= 14). Increasing
the Shh-N concentration from 400 to 1000 nM did not appear to
alter the outcome. When we instead used the hedgehog agonist
Hh-Ag1.3 (n = 9, 1.5 mM), 95–100% of the differentiated neurons
expressed MN markers (Figure 8). This suggests that at these
concentrations, the agonist may be more effective than the actual
peptide in generating MNs from FT-derived neurospheres.
We also varied the differentiation conditions to determine which
factors were essential for generating MNs from the FT. The
following conditions were used: (1) neurospheres were treated as
described above (with RA and Shh) and then differentiated in
media containing serum along with BDNF, CNTF, and GDNF
(n= 25); (2) neurospheres were treated with Shh-N but without RA
(n= 8) followed by the addition of serum and the three
neurotrophins; (3) untreated neurospheres were cultured in media
containing serum and the three neurotrophins (n = 8); and (4)
untreated neurospheres were differentiated in media containing
serum without the addition of neurotrophic factors (n = 3). Under
conditions (2) and (3), neurospheres consistently generated a
variable proportion of MNR2+ cells (5–67%). In condition (4), the
generation of MNs was inconsistent (Figure 8). In 1/3 of the cases,
40% of cells derived from the neurosphere expressed MNR2, and
in 2/3 cases no cells were MNR2+. The use of RA and Shh-N for
directed and consistent generation of MNs did not prove superior
to simply differentiating the neurospheres in the presence of
BDNF, CNTF, and GDNF. However, Hh-Ag1.3 seems to be
beneficial in increasing the MN yield (Figure 8). Given that FT is
the vestigial remnant of the spinal cord, these results may indicate
an innate potential of some FT NPCs to differentiate into MNs
without either the caudalizing action of RA or exogenous
ventralizing Shh signaling.
Figure 6. Heterogeneous differentiation potential of FT-derived neurospheres. This scatter graph illustrates the variability in the
expression of Tuj-1 (neuronal marker) and GFAP (astrocytic marker) in 14 neurosphere differentiation experiments. Individual neurospheres were
differentiated by both attachment to an adhesive substrate (poly-L-lysine- and laminin-coated coverslips) and exposure to 5% serum. Differentiated
cells were evaluated by immunocytochemistry after either 24 hours or 7–10 days. In both cases, a variable proportion of neurons and astrocytes was
observed. The approximate proportion of differentiated cells from a neurosphere that co-stained for both markers decreased after 7–10 days of
exposure to the differentiating conditions relative to the proportion of overlap noted after 24 hours.
doi:10.1371/journal.pone.0065974.g006
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Muscle co-culture and neuromuscular junction (NMJ)
formation
To assess the potential of FT-derived MNs to innervate muscle,
we used the same motor neuron/muscle co-culture system that we
had previously developed for human FT-derived NPCs [51].
Single neurospheres were treated with RA & Shh and co-cultured
with postnatal rat striated muscle fibers under differentiating
conditions in the presence of BDNF, CNTF, and GDNF (n= 24).
To confirm that the neurons observed in the co-culture were
derived from plated neurospheres, 14 neurospheres were pre-
incubated with either a lipophilic carbocyanine dye (Di-I or DI-D;
Figure 9a,b) or carboxyfluorescein diacetate succinimidyl ester
(CFSE; Figure 9c). Treated neurospheres were co-cultured with
muscle for 6–21 days and then incubated with fluorescent a-
bungarotoxin to mark the nicotinic acetylcholine receptors and
identify the presence of neuromuscular junctions. After 6–21 days,
clustered a-bungarotoxin staining on muscle fibers was detected in
all of the co-cultures (Figure 9c). In contrast, control cultures
containing muscle fibers only do not contain neuromuscular
junctions as defined by acetylcholine receptor clustering [51].
These findings are highly suggestive that FT-derived neurospheres
have the potential to form neuromuscular junctions.
FT-derived neurospheres can differentiate into neurons
and glia in vivo
Because FT-derived neurospheres could differentiate into both
neurons (including motor neurons) and glia in vitro, we wanted to
examine the behavior of these cells when they were reintroduced
to the spinal cord in vivo. To accomplish this, the FT was isolated
from transgenic rats aged P0–P2 in which all cells express GFP
under the control of the chicken b-actin promoter and cytomeg-
alovirus enhancer (SD-Tg(Act-EGFP)CZ-004Osb; SLC Japan).
Neurospheres were isolated and cultured from this tissue as
previously described (Figure 10a). These FT-derived, GFP+
neurospheres were implanted into the neural tube of stage 10–
15 chick embryos at the rostral end of the developing spinal cord
(Figure 10b; n= 31). In some cases, the neurospheres were
dissociated before being implanted. The embryos were then
permitted to develop for an additional 3–7 days post-transplan-
tation before their ability to survive, migrate into the host tissue,
and differentiate was assessed.
An analysis of the spinal cord from these operated chick
embryos 3 days post-implantation revealed the presence of a
number of GFP+ cells that had not only survived but had migrated
away from the injection site into the developing chick spinal cord
(n= 27). These cells clearly had the morphology of neurons and
glia (Figure 10c). After 7 days, immunohistochemical analysis
revealed that a subset of these transplanted GFP+ cells could be
identified as neurons (Figure 10f; n = 12), astrocytes (Figure 10g;
n = 9), and oligodendrocytes (Figure 10 h; n = 9) by their
expression of the immunohistochemical markers Tuj-1, GFAP,
and myelin basic protein (MBP), respectively. In addition, we also
implanted FT-derived cells from human donors aged 3 months to
2 years into the developing chick spinal cord (n = 8; see [51] for
details on how human FT-derived NPCs were obtained). These
human NPCs were also able survive, migrate away from the
injection site, and differentiate into both neurons and glia over the
course of 3–5 days (n = 5; Figure 10d,e). This preliminary result
suggests that rat and human FT-derived NPCs have the ability to
differentiate into both neurons and glia in vivo. We have not yet
been able to follow the chicks’ development for a sufficient period
of time to determine whether these cells have the ability to
integrate into the host nervous system.
Discussion
The results of this study demonstrate that multipotent stem/
progenitor cells are present in the postnatal FT. These cells exhibit
two cardinal properties of NPCs: they are capable of both self-
renewal/expansion and of differentiation into multiple cell types,
including neurons, astrocytes, and oligodendrocytes [61]. The
results described here are consistent with the findings of three
previous studies including one from our own lab, which have all
demonstrated that neural stem/progenitor cells can be derived
from the postnatal human FT [49–51]. One of these reports had
suggested that the rat FT was also capable of producing NPCs;
however, the observed efficiency in that study was only 39% [50].
Here, we have optimized the rat neurosphere assay to achieve a
96% culture success rate at a range of donor ages. Presumably, the
improved efficiency is due to this being an extended study
involving large numbers of rats. In addition, we have demonstrat-
ed that FT-derived NPC cells can be differentiated into MNs. The
ability of the FT to generate MNs may be of particular therapeutic
significance for neurodegenerative diseases such as amyotrophic
lateral sclerosis (ALS). The cells were not assessed for clonality
because this is not immediately applicable therapeutically [2,3].
We reasoned that so long as FT-derived NPCs can be produced in
large enough numbers to permit cell replacement strategies,
clonality is not essential to the therapeutic strategy.
The neurosphere assay
We employed the neurosphere assay for isolating and expanding
NPCs. As observed in this study, individual neurospheres
demonstrate the two classic NPC properties: self-renewal and
multipotency, which suggests that the FT-derived cells are in fact
neural progenitors. For the past 20 years, the most widely used
technique for culturing NPCs has been to utilize non-adherent
conditions under which these cells aggregate and form spheres of
Figure 7. Generation of motor neurons (MNs) from FT-derived
neurospheres. Individual neurospheres were treated with RA and
either Shh-N or Hh-Ag1.3 for 4–5 days, plated onto an adhesive
substrate, and cultured in serum-containing medium with appropriate
growth factors for 7–10 days. Differentiated cells were subsequently
evaluated for the expression of MN and MN progenitor markers. a)
Differentiated cells from a P7 FT (30 DIV) stained positive for Olig2 (i,
red) Pax6 (ii, green). The merged images co-stained for DAPI (blue) are
shown in (iii). b) The MN-specific marker MNR2 is expressed by FT-
derived neurospheres (green). Donor: P7 FT, 30 DIV. c) Expression of
Tuj-1 (i, green) and ChAT (ii, red). The merged image co-stained for DAPI
is shown in (iii). Donor: P6 FT, 36 DIV. Scale bars: 100 mm.
doi:10.1371/journal.pone.0065974.g007
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proliferating cells called neurospheres [9,62]. However, recent
studies have raised some issues regarding the limitations of the
neurosphere assay. One concern has been that a single neuro-
sphere may contain a heterogeneous population of cells, and
culture conditions may favor the growth and survival of one type
of cell over another. In fact, each neurosphere may contain only a
small number of NPCs that would then become diluted with each
passage [62]. One non-neuronal cell type likely to be present
initially in the neurospheres is ependymal cells, which line the
central canal of the FT. However, these cells are postmitotic [63]
and are diluted out with each passage; therefore, they are unlikely
to contribute to the population of dividing cells observed in this
study. Additionally, the neurosphere assay may not take into
account quiescent cells that are residing in G0 at the time of
neurosphere formation [64]. Cell density is another concern
because as the neurosphere grows, it becomes difficult for nutrients
to reach the innermost cells, and a necrotic center may begin to
form [65].
Thus, some groups instead prefer to utilize a monolayer assay
where NPCs are grown under adherent conditions to form a single
Figure 8. Variable expression of MNR2 in FT-derived neurospheres undergoing MN differentiation. Scatter graph illustrating the
variability in MNR2 expression in differentiated neurospheres under four sets of differentiation conditions. The X axis is the experiment number, and
the Y axis is the average proportion of cells derived from each neurosphere expressing MNR2, Tuj-1 and/or GFAP. MNR2, which was used to identify
MN generation, was expressed by cells in roughly the same proportion among conditions (1), (2), and (3) with more inconsistent results under
condition (4). In 3 of the 28 experiments where the small molecule agonist, Hh-Ag1.3, was used in place of Shh-N, 100% expression of MNR2 was
observed. See Results for more detail.
doi:10.1371/journal.pone.0065974.g008
Figure 9. Neuromuscular junction formation. a) A single neurosphere derived from a P6 FT was treated for 24 hours with Shh and RA and then
labeled with DiI. b) A cell derived from the DiI-labeled neurosphere that has been co-cultured with rat myocytes for 2 days. c) After 20 days of co-
culture, muscle cells were labeled with a-bungarotoxin-AF594 (red) to identify acetylcholine receptors clustered at neuromuscular junctions. Cells
derived from individual neurospheres were pre-labeled with CFSE (green) prior to being added to the co-culture.
doi:10.1371/journal.pone.0065974.g009
Multipotent Cells from the Rat filum terminale
PLOS ONE | www.plosone.org 10 June 2013 | Volume 8 | Issue 6 | e65974
layer of cells. This results in a more homogeneous population of
cells and reduces the level of spontaneous differentiation among
the NPCs [64]. Recently, we have started culturing FT-derived
NPCs under monolayer-forming conditions with encouraging
success, and we intend to employ this method going forward.
Cell identity manifests after 7–10 days in differentiating
conditions but may be determined prior to the
differentiation process
We compared neuronal and glial marker expression in single
neurospheres that had been differentiated for 24 hours versus 7–
10 days. After 24 hours, most cells expressed both sets of markers,
which may reflect an unresolved cell fate early on in the
differentiation process. In contrast, after 7–10 days, most cells
derived from a single neurosphere expressed either a neuronal or a
glial marker with very few cells double staining for both. This did
not vary with donor age and may be the result of cells expressing a
more committed cell fate over an extended period of time
compared with a relatively ambiguous cell identity after 24 hours.
Cell identity may also be determined prior to the differentiation
process. Before differentiation, neurospheres expressed different
patterns of Tuj-1 and GFAP staining despite identical treatment.
While some cells within a neurosphere indicated double staining
for both markers, most expressed only a single marker. Cells
positive for the same marker tended to cluster together spatially.
This is consistent with reports of heterogeneous neurospheres that
have been derived from other adult CNS and embryonic sources
[59,60,66]. Suslov et al. (2002) studied the cDNA libraries of 30
neurosphere clones and found that they all differentially expressed
transcripts. This group also demonstrated that neurospheres
contained NSCs as well as neuronal and glial progenitors in
different stages of differentiation with distinct neural developmen-
tal commitments [60].
It is possible that the neuronal or glial characteristics acquired
prior to neurosphere differentiation may predict the differentiation
potential of each neurosphere. Temporary double staining during
early stages of differentiation may represent a point along the
differentiation pathway where cell fate remains ambiguous. Early
staining patterns among neurosphere cells (GFAP+ or Tuj-1+)
before differentiation potentially implies that manipulating neuro-
spheres towards a more neuronal or glial fate may require
culturing them in different conditions from the outset.
Neural progenitor cell (NPC) markers persist at 7–10 days
NPC marker expression was high after 24 hours of differenti-
ation and even higher after 7–10 days. This was surprising because
most cells by this point begin to express markers representing a
more mature phenotype, i.e., a neuronal or glial cell marker. Cells
that persist in expressing NPC markers in addition to neuronal- or
glial-specific markers may be lineage-specific NPCs. Alternatively,
this persistence and/or increase in NPC marker staining may be a
tissue culture artifact.
FT-derived neurospheres have an innate potential to
generate MNs
FT-derived neurospheres generated MNs with and without
exposure to RA and Shh, which have both been previously used to
differentiate embryonic stem cells into MNs in vitro [67–69].
Rostral neural progenitors in embryoid bodies acquire a spinal
positional identity in response to RA (a caudalizing signal) and
subsequently attain a motor neuron progenitor identity in response
to the ventralizing signals of Shh [69–72]. BDNF, CNTF, and
GDNF are neurotrophins that are known to support MN growth
and survival [73–76]. FT-derived neurospheres that were treated
with RA and Shh-N prior to differentiation in media containing
serum, BDNF, CNTF, and GDNF generated 20–40% MNs.
Neurospheres plated in serum with BDNF, CNTF, and GDNF
without RA or Shh-N treatment generated between 5–67% MNs,
which suggests that treating FT-derived neurospheres with Shh-N
Figure 10. In vivo survival and differentiation of FT-derived
NPCs transplanted into the developing chick spinal cord. a)
Neurospheres were isolated from a P2 transgenic rat that expressed
eGFP in every cell. Scale bar: 100 mm. b) GFP+ NPCs from a P2 rat were
transplanted into a stage 10 (33 hrs) chick neural tube at the
prospective rostral end of the developing spinal cord. This image was
taken immediately after injection, and the rostral end is pointing
towards the bottom. Scale bar: 200 mm. c) After 3 DIO (,stage 22), GFP+
cells had survived and begun to take on the morphology of neurons
and glia. Scale bar: 50 mm. d–e) Neurospheres from a 6-month-old
human were transplanted into a stage 10 (33 hrs) chick spinal cord at
the rostral end. After 3 DIO, transplanted cells were labeled with the
human-specific antibody HSP27 (green) and can be seen migrating
away from the transplantation site. Two different embryos are shown in
(d) and (e). The image in (e)i is a magnified view of the migrating cells
from the highlighted area in (e). Scale bars: (d) and (e): 200 mm, (e)i:
50 mm. f–h) After 7 DIO, some FT-derived NPCs (green, f–h(i)) expressed
the neuronal marker Tuj-1 (red, f(ii)), the astrocyte marker GFAP (red,
g(ii)), or the oligodendrocyte marker MBP (red, h(ii)). In all cases (f–h), a
merged image of (i) and (ii) along with the nuclear marker DAPI is
shown in (iii). Scale bars: 50 mm.
doi:10.1371/journal.pone.0065974.g010
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and RA is not more effective in generating MNs than plating them
in the presence of BDNF, CNTF, and GDNF alone. While RA
and Shh are crucial in directing embryonic stem cell differenti-
ation into MNs, they may not be as critical to a subset of FT-
derived NPCs, which have possibly been caudalized and
ventralized during embryonic development. When FT derived
neurospheres were plated in serum alone, 1/3 generated 40%
MNs, indicating that occasional MN differentiation can occur
without addition of RA/Shh-N or growth factors. This may be
due to the critical factors being present in the serum at sufficient
concentrations to stimulate NPCs in the FT which possess an
innate potential to produce MNs. NPCs from the FT may possess
an intrinsic ability to generate cell types (such as MNs) that reside
in the spinal cord.
Hh-Ag 1.3 may be more effective than Shh-N at
increasing MN yield from FT-derived neurospheres
In addition to Shh-N, Shh signaling is also activated by the
small molecule agonist Hh-Ag 1.3. To generate MNs from ESCs,
previous studies have used either 300–500 nM Shh-N or 1–2 mM
Hh-Ag 1.3 [54,67–69,77]. Although Wichterle et al. (2002)
reported identical results with Shh-N and Hh-Ag 1.3 at these
concentrations, most studies have used 1 mM Hh-Ag 1.3 to
generate MNs from ESCs [67,68,77,78]. In FT-derived neuro-
spheres, Hh-Ag1.3 was particularly effective in increasing the yield
of generated MNs when compared to Shh-N. In the presence of
Hh-Ag1.3, nearly 100% of differentiated cells were MNs and this
number decreased to 20–40% when Shh-N was used instead.
Therefore, a discrepancy exists between the increased efficacy of
Hh-Ag 1.3 in FT-derived neurospheres versus ESC-derived
neurospheres.
GFAP+ cells derived from FT-derived neurospheres may
not be astrocytes
In this study, we used GFAP to identify astrocytes. However,
this protein is also a marker for astrocyte-like adult stem cells
[61,79]. In adult mammals, neurogenic astrocytes have been
identified in vivo in both the SVZ of the lateral ventricle and the
subgranular zone of the dentate gyrus in the hippocampus [61,80].
The characteristics and markers that distinguish neurogenic
astrocytes from the vast population of non-neurogenic astrocytes
remain unknown [61]. GFAP+ cells differentiated from FT-derived
NPCs may consist of neurogenic and/or non-neurogenic astro-
cytes. In our differentiation experiments, cells sometimes double
stained for both GFAP and a neuronal marker. For example, FT-
derived NPCs that have undergone directed MN differentiation
sometimes expressed both MNR2 and GFAP. The concurrent
expression of a MN marker with GFAP would be surprising if
GFAP were solely a non-neurogenic astrocyte marker. However,
because GFAP is also a marker for astrocyte-like adult NPCs,
double-stained cells may represent neurogenic astrocytes that are
committed to an MN cell fate.
In conclusion, we have demonstrated that FT-derived neuro-
spheres proliferate, can be passaged in vitro, and can differentiate
into a collection of NPCs, neurons, and glia. The discovery of
multipotent cells within the mammalian CNS has had tremendous
implications for therapeutic possibilities in many currently
incurable CNS diseases, including trauma, Alzheimer’s, Parkin-
son’s, ALS, and multiple sclerosis [1,81]. The establishment of the
FT as a source of multipotent cells opens up new possibilities in the
field of autologous transplantation therapy for these neurological
diseases. It is important to fully explore the potential of these cells
both in vivo and in vitro. The use of a rat model permits a systematic,
unlimited study of these cells in a controlled environment.
Although cells derived from each animal and even each neuro-
sphere are a heterogeneous population, they all have the ability to
divide and to differentiate into both neurons and glia either
spontaneously or in a directed manner. Even after these FT-
derived cells are frozen for extended periods of time and then
subsequently thawed, they still retain the same potential to
produce both neurons and glia. This suggests that cells can be
collected, frozen, and then later recovered and used for
therapeutic purposes. Additionally, because the rat and mouse
nervous systems are so closely related, it seems reasonable to
expect that the methods that we have developed here will be
directly applicable to the mouse. This will allow the use of the
large number of already established transgenic lines that have been
developed by various stem cell groups. The principles learned
from this model may be directly applied to postnatal human FT-
derived NPCs for potential therapeutic purposes.
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